APELLIS PHARMACEUTICALS INC's ticker is APLS and the CUSIP is 03753U106. A total of 217 filers reported holding APELLIS PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 1.07 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1,879 | +595.9% | 162,622 | +530.8% | 0.19% | +407.9% |
Q2 2023 | $270 | -19.2% | 25,779 | -5.2% | 0.04% | +11.8% |
Q1 2023 | $334 | -35.0% | 27,200 | -69.4% | 0.03% | -20.9% |
Q4 2022 | $514 | -100.0% | 88,875 | +22.4% | 0.04% | -41.1% |
Q3 2022 | $1,076,000 | +30.7% | 72,600 | +10.6% | 0.07% | +25.9% |
Q2 2022 | $823,000 | +45.1% | 65,663 | +4.8% | 0.06% | +100.0% |
Q1 2022 | $567,000 | +89.6% | 62,663 | +426.9% | 0.03% | +141.7% |
Q4 2021 | $299,000 | -92.7% | 11,893 | -96.6% | 0.01% | -93.5% |
Q3 2021 | $4,119,000 | +958.9% | 351,285 | +1496.8% | 0.18% | +927.8% |
Q2 2021 | $389,000 | +872.5% | 22,000 | +566.7% | 0.02% | +800.0% |
Q1 2021 | $40,000 | +73.9% | 3,300 | +312.5% | 0.00% | +100.0% |
Q4 2020 | $23,000 | +475.0% | 800 | -66.7% | 0.00% | – |
Q3 2020 | $4,000 | -94.8% | 2,400 | -71.4% | 0.00% | -100.0% |
Q2 2020 | $77,000 | -64.8% | 8,400 | -58.8% | 0.01% | -54.5% |
Q1 2020 | $219,000 | +59.9% | 20,400 | -31.1% | 0.01% | +37.5% |
Q4 2019 | $137,000 | +85.1% | 29,600 | +504.1% | 0.01% | +14.3% |
Q3 2019 | $74,000 | – | 4,900 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Octagon Capital Advisors LP | 3,130,000 | $119,065,200 | 18.29% |
EcoR1 Capital, LLC | 10,899,859 | $414,630,636 | 13.99% |
Ally Bridge Group (NY) LLC | 181,805 | $6,915,862 | 8.12% |
Avoro Capital Advisors LLC | 11,111,111 | $422,666,662 | 6.59% |
ACUTA CAPITAL PARTNERS, LLC | 244,484 | $9,300,171 | 6.23% |
Iron Triangle Partners LP | 880,000 | $33,475,200 | 4.89% |
Cormorant Asset Management, LP | 2,000,000 | $76,080,000 | 4.44% |
Octagon Capital Advisors LP | 675,000 | $25,677,000 | 3.94% |
Logos Global Management LP | 750,000 | $28,530,000 | 3.81% |
Boxer Capital, LLC | 1,726,000 | $65,657,040 | 3.50% |